Staying Positive During the Pandemic

The good news for patients in need of outpatient surgery is that, across the country, health care providers and policymakers have recognized that elective surgery is not the same thing as optional surgery and are allowing ASCs to remain open to provide this care.

Handling of Explanted Medical Devices Addressed in AORN’s Revised Guideline for Specimen Management

SP professionals must manage explants safely and properly any time a request is made to sterilize an explanted device, such a screw, hip, plate and so on, for return to the patient.

Disinfection Methods – Straightforward or Complicated?

With all the different cleaning, disinfecting and sterilizing processes that go on inside of hospitals, I find disinfection to be the most complex and complicated among them.

Steam Sterilization Standard ST79 Receives Community-Driven Update

After three years, a widely used standard in health care and industry has undergone an important update.

Ambu Expands GPO Contracts

Ambu Inc. has been granted national single-use endoscopy contract expansions with two U.S. group purchasing organizations (GPOs). With these expansions, Ambu is now on contract with four major GPOs in the U.S. with either a full or partial portfolio of single-use endoscopy categories available for these GPO customers.

On one contract, Ambu’s aScope 4 Cysto has been added, while Ambu’s aScope Duodeno has been added on another. The expanded agreements strengthen Ambu’s position in single-use bronchoscopes, rhinolaryngoscopes and now cystoscopes and duodenoscopes for the duration of the contracts.

The aScope 4 Cysto addition expands the single-use endoscopy category of an existing contract and will be effective immediately through November 2023. The expansion enables Ambu to more broadly serve 160 acute care hospitals in the U.S. and over 2,600 total sites across more than 20 states. This expanded agreement will further accelerate growth of Ambu’s share of the single-use endoscope market by giving those accounts pre-negotiated terms for Ambu’s bronchoscopy, rhinolaryngoscopy and cystoscopy products.

The aScope Duodeno addition to the existing contract with another major GPO, meanwhile, provides access to Ambu’s entire suite of single-use endoscopes and will be effective through February 2022. This enables Ambu to serve more than 50% of the acute care hospitals in the U.S. This agreement will further accelerate Ambu’s rapidly expanding share of the single-use endoscope market by giving those accounts pre-negotiated terms for Ambu’s duodenoscopes.

In total, these contract expansions give 90% of U.S. hospitals access to Ambu’s complete line of single-use endoscopes; 98% of U.S. hospitals have access to Ambu’s rhinolaryngoscopes, bronchoscopes and cystoscopes. Three of the four major GPOs have now created specific single-use endoscope categories.

“We’re very excited to see that GPOs, with existing contracts, are adding newly released products to expand the dedicated single-use endoscopy categories, serving hospitals and healthcare providers to provide a broader array of advanced single-use devices,” said Steven Block, president of Ambu Inc., North America. “In particular, our duodenoscope contract expansion will accelerate adoption of single-use endoscopy in GI and provide hospitals with additional opportunities to follow the FDA recommendations to transition to new and innovative duodenoscope designs.”

For more information, visit or



Submit a Comment

Your email address will not be published. Required fields are marked *